Overview
- 7 FDA inspections are on record.
- 4 inspections produced a Form 483.
- The most recent recorded inspection date is 2022-05-24.
At a glance
Inspections
7
Form 483s
4
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 9 May 2022 – 24 May 2022 | Medical Devices & Rad Health | 483 | View 483 → |
| 19 Sep 2016 – 22 Sep 2016 | Medical Devices & Rad Health | Clean | |
| 14 Oct 2014 – 14 Nov 2014 | Medical Devices & Rad Health | WL | View 483 → |
| 28 Jun 2011 | Not recorded | 483 | View 483 → |
| 29 Oct 2010 | Not recorded | WL | View 483 → |
| 17 Feb 2005 | Not recorded | Clean | |
| 1 Apr 2004 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
24 May 2022
21 CFR 820.30(i)
Design changes - Lack of or Inadequate Procedures
Cited by Maryam Tabatabaie
Investigators
FDA investigators tied to this site in the record.
Maryam Tabatabaie2 insp.
Elizabeth B Griffin2 insp.
Stephen C Smith1 insp.
Justine M Corson1 insp.
Camerson E Moore1 insp.
Charles R Clavet1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 820.198(a) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 820.50 | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 820.80(a) | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 806.20(b)(4) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 820.30(i) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 820.72(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 820.30(g) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 820.140 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.181 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.40 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.75(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.150(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.184 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.22 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.250(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.70(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.70(g) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.70(g)(1) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.70(i) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.75(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.80(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 820.90(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Verichem Laboratories, Inc.'s 4 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat